학술논문

Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission...
Document Type
Article
Source
Lancet. 9/5/1992, Vol. 340 Issue 8819, p565. 4p. 4 Diagrams, 3 Charts, 3 Graphs.
Subject
*CANCER treatment
Language
ISSN
0140-6736
Abstract
Focuses on results of the recent MRC UKALL X trial, which was designed to facilitate a non-randomized comparison between bone marrow transplantation (BMT) and chemotherapy in children deemed to be at high risk of treatment failure. High-risk acute lymphoblastic leukemia (ALL) in first remission; Clinical features in patients given chemotherapy or BMT; Events in chemotherapy and BMT groups; More.